Advances in military, field, and austere transfusion medicine in the last decade

Transfusion and Apheresis Science

Volumn 49, Issue 3, 2013, Pages 380-386

  Hess, John R ^a   Lelkens, Charles C M ^b   Holcomb, John B ^c   Scalea, Thomas M ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Royal Netherlands Navy ^*  (Netherlands)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Biologicals; Blood product development; Blood product regulation; Medical logistics; Plasma derivatives

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN CONCENTRATE; PROTHROMBIN COMPLEX;

ARMY; ARTICLE; BLOOD; BLOOD TRANSFUSION; EMERGENCY HEALTH SERVICE; ERYTHROCYTE TRANSFUSION; FREEZE DRYING; HUMAN; MEDICAL CARE; PLASMA TRANSFUSION; RESUSCITATION; SHELF LIFE; THAWING; THROMBOCYTE TRANSFUSION;

BIOLOGICALS; BLOOD PRODUCT DEVELOPMENT; BLOOD PRODUCT REGULATION; MEDICAL LOGISTICS; PLASMA DERIVATIVES;

BLOOD TRANSFUSION; DISASTERS; HUMANS; MILITARY MEDICINE; TRANSFUSION MEDICINE; WOUNDS AND INJURIES;

EID: 84888431990     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.06.015     Document Type: Article

References (46)

1. Holcomb J.B., Spinella P.C. Optimal use of blood in trauma patients. Biologicals 2010, 38:72-77.
2. Hess J.R., Thomas M.J.G. Blood use in war and disaster: lessons from the last century. Transfusion 2003, 43:1622-1633.
3. Rotondo M.F., Schwab C.W., McGonigal M.D., Phillips G.R., Fruchterman T.M., Kauder D.R., et al. Damage control': an approach for improved survival in exsanguinations penetrating abdominal injury. J Trauma 1993, 35:375-382.
4. Thorson C.M., Dubose J.J., Rhee P., Knuth T.E., Dorlac W.C., Bailey J.A., et al. Military trauma training at civilian centers: a decade of advancements. J Trauma Acute Care Surg 2012, 73(6 Suppl. 5):S483-S489.
5. Bickell W.H., Wall M.J., Pepe P.E., Martin R.R., Ginger V.F., Allen M.K., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994, 331:1105-1109.
6. Dutton R.P., Mackenzie C.F. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002, 52:1141-1146.
7. Simmons R.L., Collins J.A., Heisterkamp C.A., Mills D.E., Andren R., Phillips L.L. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg 1969, 169:455-482.
8. Hardaway R.M. Shock and disseminated intravascular coagulation. Thromb Diath Haemorrh 1966, 20(Suppl.):121-146.
9. Levi M., Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592.
10. Armand R., Hess J.R. Treating coagulopathy in trauma patients. Transfus Med Rev 2003, 17:223-231.
11. Brohi K., Singh J., Heron M., Coats T. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
12. MacLeod J.B., Lynn M., McKenney M.G., Cohn S.M., Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003, 55:39-44.
13. Hess J.R., Lindell A.L., Stansbury L.G., Dutton R.P., Scalea T.M. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion 2009, 49:34-39.
14. Hess J.R., Brohi K., Dutton R.P., Hauser C.J., Holcomb J.B., Kluger Y., et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008, 65:748-754.
15. Taylor F.B., Toh C.H., Hoots W.K., Wada H., Levi M. Scientific subcommittee on disseminated intravascular coagulation (DIC) of the international society on thrombosis and haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemostol 2001, 86:1327-1330.
16. Niles S.E., McLaughlin D.F., Perkins J.G., Wade C.E., Li Y., Spinella P.C., et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma 2008, 64:1459-1463.
17. Cannon W.B., Fraser J., Cowell E.M. The preventive treatment of wound shock. J Am Med Assoc 1918, 70:618-621.
18. Beecher H.K. Preparation of battle casualties for surgery. Ann Surg 1945, 21:769-792.
19. Carrico C.J., Canizaro P.C., Shires G.T. Fluid resuscitation following injury: rationale for the use of balanced salt solutions. Crit Care Med 1976, 4:46-54.
20. Moore F.D., Shires G.T. Moderation. Anesth Analg 1968, 47:506-508.
21. Bickell W.H., Bruttig S.P., Millnamow G.A., O'Benar J., Wade C.E. The detrimental effects of intravenous crystalloid after aortotomy in swine. Surgery 1991, 110:529-536.
22. Bickell W.H., Wall M.J., Pepe P.E., Martin R.R., Ginger V.F., Allen M.K., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994, 331:1105-1109.
23. Malone D.L., Hess J.R., Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006, 60(6 Suppl.):S91-S96.
24. Como J.J., Dutton R.P., Scalea T.M., Edelman B.B., Hess J.R. Blood transfusion rates in the care of acute trauma. Transfusion 2004, 44:809-813.
25. Borgman M.A., Spinella P.C., Perkins J.G., Grathwohl K.W., Repine T., Beekley A.C., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
26. Cotton B.A., Gunter O.L., Isbell J., Au B.K., Robertson A.M., Morris J.A., et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008, 64:1177-1182.
27. Kautza B.C., Cohen M.J., Cuschieri J., Minei J.P., Brackenridge S.C., Maier R.V., et al. Inflammation and the host response to injury investigators. Changes in massive transfusion over time: an early shift in the right direction?. J Trauma 2012, 72:106-111.
28. Holcomb J.B., Del Junco D.J., Fox E.E., Wade C.E., Cohen M.J., Schreiber M.A., et al. For the PROMMTT study group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. Arch Surg 2012, 15:1-10.
29. ClinicalTrials.gov Identifier NCT01545232.
30. Hmel P.J., Kennedy A., Quiles J.G., Gorogias M., Seelbaugh J.P., Morrissette C.R., et al. Physical and thermal properties of blood storage bags: implications for shipping frozen components on dry ice. Transfusion 2002, 42:836-846.
31. Kendrick D.B. Blood program in world war II 1964, Office of the Surgeon General, Washington DC.
32. Flamholz R., Jeon H.R., Baron J.M., Baron B.W. Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?. J Clin Apher 2000, 15:169-172.
33. Solheim B.G., Seghatchian J. Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apher Sci 2006, 35(1):83-90.
34. Schöchl H., Nienaber U., Hofer G., Voelckel W., Jambor C., Scharbert G., et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14(2):R55.
35. Görlinger K., Fries D., Dirkmann D., Weber C.F., Hanke A.A., Schöchl H. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012, 39:104-113.
36. Joseph B., Amini A., Friese R.S., Houdek M., Hays D., Kulvatunyou N., et al. Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 2012, 72:828-834.
37. Innerhofer P., Westermann I., Tauber H., Breitkopf R., Fries D., Kastenberger T., et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013, 44:209-216.
38. McSwain N., Barbeau J. Potential use of prothrombin complex concentrate in trauma resuscitation. J Trauma 2011, 70(5 Suppl.):S53-S56.
39. Lazarus H.M., Kaniecki-Green E.A., Warm S.E., Aikawa M., Herzig R.H. Therapeutic effectiveness of frozen platelet concentrates for transfusion. Blood 1981, 57(2):243-249.
40. Valeri C.R., Srey R., Lane J.P., Ragno G. Effect of WBC reduction and storage temperature on PLTs frozen with 6 percent DMSO for as long as 3 years. Transfusion 2003, 43:1162-1167.
41. Schiffer C.A., Aisner J., Wiernik P.H. Clinical experience with transfusion of cryopreserved platelets. Br J Haematol 1976, 34:377-385.
42. Daly P.A., Schiffer C.A., Aisner J., Wiernik P.H. Successful transfusion of platelets cryopreserved for more than 3 years. Blood 1979, 54:1023-1027.
43. Khuri S.F., Healey N., MacGregor H., Barnard M.R., Szymanski I.O., Birjiniuk V., et al. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999 Jan, 117(1):172-183.
44. Lelkens C.C., Koning J.G., de Kort B., Floot I.B., Noorman F. Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006, 34:289-298.
45. Neuhaus S.J., Wishaw K., Lelkens C. Australian experience with frozen blood products on military operations. Med J Aust 2010, 192:203-205.
46. Abolghasemi H., Radfar M.H., Tabatabaee M., Hosseini-Divkolayee N.S., Burkle F.M. Revisiting blood transfusion preparedness: experience from the Bam earthquake response. Prehosp Disaster Med 2008, 23:391-394.